MiR-129-5p levels were decreased in mouse depression models. حسب Qiaozhen Qin (13159201)

"…The Y-axis represents the fold change, while the X-axis indicates the significance of differential expression. The gray points represent miRNAs with no significant change (p < 0.05, false discovery rate (FDR) q < 0.05), while red and blue points indicate upregulated and downregulated miRNAs (p < 0.05, FDR q < 0.05), respectively. …"

Elevated concentrations of serum MMA among participants with decreased cognitive performance. حسب Yige Liu (11940344)

Significantly Enriched Pathways. حسب Jiyong Zhang (2498740)

Mean ± SD values of unipedal stance parameters evaluated at the different time points of the postural training session. حسب Cristina Dolciotti (16317330)

Middle cerebral artery mean flow velocity at three time points. حسب Marco Carbonara (11483575)

الموضوعات:

PAP I point mutations lead to a decrease in pYV PCN, plasmid stability, and T3SS activity. حسب Katherine Schubert (5452712)

The mean and standard deviation of parameters. حسب Sadaf Sepasgozar Sarkhosh (20436143)

الموضوعات:

Transcriptome sequencing enriched sarcopenia related GO Biological process (BP) and Molecular function (MF). Enriched GO BP of DEGs. حسب Wenbin Wu (292223)

Decreased virulence observed during <i>in planta</i> infection with <i>ΔFgknr4</i>. حسب Erika Kroll (20537020)

"…</b> Wheat spike infection assay done on the susceptible cultivar Bobwhite point inoculated with sterile water only (M), wild-type <i>F</i>. …"

KEGG pathway enrichment analysis of lactoferrin and Coenzyme Q10 in sarcopenia. حسب Wenbin Wu (292223)

Summary of post-treatment disease course measures from MDMA-AT publications. حسب Filip Stanicic (17808254)

الموضوعات:

Study selection criteria. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. حسب Filip Stanicic (17808254)

الموضوعات:

Disease course measures after the PTSD treatments. حسب Filip Stanicic (17808254)

الموضوعات:

PICOS criteria for the SLR. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment CAPS score changes from MDMA-AT publications. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment disease course measures from off-label medications clinical trials. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment disease course measures from clinical trials with psychotherapies. حسب Filip Stanicic (17808254)

الموضوعات: